Feed NRC
NR
National Research Corporation
NRC · NASDAQ
$22.01 -0.07% (-$0.01)
1M +2.80%
Market Cap $496.0M
P/E Ratio 84.69x
Div. Yield 2.73%
ROE 48.46%
Bulios Fair Price
$16.61
24.5% downside
Preț actual
$22.01
Subevaluat Valoare justă Supraevaluat
Potrivit Bulios Fair Price, acțiunile NRC sunt în prezent supraevaluate față de prețul lor de piață. Cum funcționează?
Piotroski F-Score Moderate
6/9Valuation
22 /100
Expensive P/E 84.69x
P/FCF 22.92x
EV/EBITDA 28.05x
Growth
1 /100
Declining EPS growth 25.74%
Book val. growth 42.09%
Rev. growth 3.22%
Profitability
63 /100
Moderate Gross margin 41.51%
FCF margin 15.46%
Net margin 4.18%
Quality
69 /100
Excellent ROIC 8.75%
Asset turnover 1.03x
ROE 48.46%
Debt
23 /100
High Debt/Equity 13.75x
Net debt/EBITDA 4.17x
Current ratio 0.65x
Stability
79 /100
Stable Beta 0.37x
Profitable years 6
Rev. volatility 1.09%
Întreabă StockBot despre NRC
Online
Sector
Healthcare
Industry
Medical - Healthcare Information Services
CEO
Trent Green
Employees
357
Headquarters
Lincoln
Evenimente viitoare
25 SEPT.
Ex-Dividend
Ex-dividend date
09 OCT.
Dividend Payment
Data plății
26 OCT.
Earnings
Upcoming earnings report